Literature DB >> 2505905

Localization of osteonectin expression in human fetal skeletal tissues by in situ hybridization.

M Metsäranta1, M F Young, M Sandberg, J Termine, E Vuorio.   

Abstract

The expression of osteonectin gene was studied in developing human fetuses by Northern analysis and in situ hybridization. The highest levels of osteonectin mRNA were detected in RNA extracted from calvarial bones, growth plates, and skin. Low mRNA levels were present in several parenchymal tissues. In situ hybridization of developing long bones revealed three cell types with high osteonectin mRNA levels: osteoblasts, cells of the periosteum, and hypertrophic chondrocytes. Weaker signals were detected in osteocytes, fibroblasts of tendons, ligaments and skin, and in cells of the epidermis. Apart from the hypertrophic chondrocytes, only low osteonectin mRNA levels were seen in cartilage. The localization of osteonectin mRNA in fetal growth plates is consistent with the hypothesis that the protein plays a role in the mineralization of bone and cartilage matrices.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2505905     DOI: 10.1007/bf02556057

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  19 in total

1.  Human pro alpha 1(I) collagen: cDNA sequence for the C-propeptide domain.

Authors:  J K Mäkelä; M Raassina; A Virta; E Vuorio
Journal:  Nucleic Acids Res       Date:  1988-01-11       Impact factor: 16.971

2.  Determination of the single polyadenylation site of the human pro alpha 1(II) collagen gene.

Authors:  K Elima; T Vuorio; E Vuorio
Journal:  Nucleic Acids Res       Date:  1987-11-25       Impact factor: 16.971

3.  Osteonectin, a bone-specific protein linking mineral to collagen.

Authors:  J D Termine; H K Kleinman; S W Whitson; K M Conn; M L McGarvey; G R Martin
Journal:  Cell       Date:  1981-10       Impact factor: 41.582

4.  Coordinated regulation of type I and type III collagen production and mRNA levels of pro alpha 1(I) and pro alpha 2(I) collagen in cultured morphea fibroblasts.

Authors:  T Vuorio; J K Mäkelä; V M Kähäri; E Vuorio
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

5.  Structure and expression of osteonectin mRNA in human tissue.

Authors:  M F Young; A A Day; P Dominquez; C I McQuillan; L W Fisher; J D Termine
Journal:  Connect Tissue Res       Date:  1990       Impact factor: 3.417

6.  Osteonectin and Gla-protein in calf bone: ultrastructural immunohistochemical localization using the Protein A-gold method.

Authors:  P Bianco; Y Hayashi; G Silvestrini; J D Termine; E Bonucci
Journal:  Calcif Tissue Int       Date:  1985-12       Impact factor: 4.333

7.  Osteonectin--a differentiation marker of bone cells.

Authors:  G Jundt; K H Berghäuser; J D Termine; A Schulz
Journal:  Cell Tissue Res       Date:  1987-05       Impact factor: 5.249

8.  Osteonectin cDNA sequence reveals potential binding regions for calcium and hydroxyapatite and shows homologies with both a basement membrane protein (SPARC) and a serine proteinase inhibitor (ovomucoid).

Authors:  M E Bolander; M F Young; L W Fisher; Y Yamada; J D Termine
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

9.  Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization.

Authors:  S Nomura; A J Wills; D R Edwards; J K Heath; B L Hogan
Journal:  J Cell Biol       Date:  1988-02       Impact factor: 10.539

10.  Developmental and transformation-sensitive expression of the Sparc gene on mouse chromosome 11.

Authors:  I J Mason; D Murphy; M Münke; U Francke; R W Elliott; B L Hogan
Journal:  EMBO J       Date:  1986-08       Impact factor: 11.598

View more
  8 in total

1.  Immunocytochemical demonstration of extracellular matrix proteins in isolated osteocytes.

Authors:  E M Aarden; A M Wassenaar; M J Alblas; P J Nijweide
Journal:  Histochem Cell Biol       Date:  1996-11       Impact factor: 4.304

2.  Expression of bone sialoprotein (BSP) in developing human tissues.

Authors:  P Bianco; L W Fisher; M F Young; J D Termine; P G Robey
Journal:  Calcif Tissue Int       Date:  1991-12       Impact factor: 4.333

3.  Histogenesis of clear cell chondrosarcoma. An immunohistochemical study with osteonectin, a non-collagenous structure protein.

Authors:  A Bosse; Y Ueda; P Wuisman; D B Jones; E Vollmer; A Roessner
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

4.  Cell proliferation, extracellular matrix mineralization, and ovotransferrin transient expression during in vitro differentiation of chick hypertrophic chondrocytes into osteoblast-like cells.

Authors:  C Gentili; P Bianco; M Neri; M Malpeli; G Campanile; P Castagnola; R Cancedda; F D Cancedda
Journal:  J Cell Biol       Date:  1993-08       Impact factor: 10.539

5.  Chondrodysplasia in transgenic mice harboring a 15-amino acid deletion in the triple helical domain of pro alpha 1(II) collagen chain.

Authors:  M Metsäranta; S Garofalo; G Decker; M Rintala; B de Crombrugghe; E Vuorio
Journal:  J Cell Biol       Date:  1992-07       Impact factor: 10.539

6.  Ganoderma lucidum, a promising agent possessing antioxidant and anti-inflammatory effects for treating calvarial defects with graft application in rats.

Authors:  Nihat Laçin; Serhat Bozan İzol; Fikret İpek; Mehmet Cudi Tuncer
Journal:  Acta Cir Bras       Date:  2019-11-25       Impact factor: 1.388

7.  Expression of tissue transglutaminase in skeletal tissues correlates with events of terminal differentiation of chondrocytes.

Authors:  D Aeschlimann; A Wetterwald; H Fleisch; M Paulsson
Journal:  J Cell Biol       Date:  1993-03       Impact factor: 10.539

8.  Transglutaminase-catalyzed matrix cross-linking in differentiating cartilage: identification of osteonectin as a major glutaminyl substrate.

Authors:  D Aeschlimann; O Kaupp; M Paulsson
Journal:  J Cell Biol       Date:  1995-05       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.